Summary
Within ten minutes after placing a phone call to say I was attending a Philadelphia conference for pharmaceutical marketing professionals who want to jump on the social media bandwagon, an electronic version of the childhood game "telephone" was in full swing. (Still fresh in the industry's collective memory is Eli Lilly's $1.4 billion in fines after its sales representatives spread unapproved claims.) Currently, the FDA has no guidelines explicitly addressing adverse event reports on networking sites like Facebook, and companies like Pfizer are not willing to take a chance that any networking activities could inadvertently step into foul territory.
See the full content of this document
Extract
Pharma On Facebook?
Within ten minutes after placing a phone call to say I was attending a Philadelphia conference for pharmaceutical marketing professionals who want to jump on the social media bandwagon, an electronic version of the child...
See the full content of this document
Sponsored links
